Related references
Note: Only part of the references are listed.Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin
Tamara I. Pestina et al.
MOLECULAR THERAPY (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Stable Long-Term Donor Engraftment following Reduced-Intensity Hematopoietic Cell Transplantation for Sickle Cell Disease
Lakshmanan Krishnamurti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation
Byoung Y. Ryu et al.
BLOOD (2008)
Late effects of myeloablative bone marrow transplantation (BMT) in sickle cell disease (SCD)
Courtney D. Fitzhugh et al.
BLOOD (2008)
A chromatin insulator blocks interactions between globin regulatory elements and cellular promoters in erythroid cells
Byoung Y. Ryu et al.
BLOOD CELLS MOLECULES AND DISEASES (2007)
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Francoise Bernaudin et al.
BLOOD (2007)
Improved human β-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element
Paritha I. Arumugam et al.
MOLECULAR THERAPY (2007)
Circumstances of death in adult sickle cell disease patients
Deepika S. Darbari et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease
EA Manci et al.
BLOOD (2006)
A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference
S Samakoglu et al.
NATURE BIOTECHNOLOGY (2006)
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin
JT Horan et al.
BONE MARROW TRANSPLANTATION (2005)
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
G Puthenveetil et al.
BLOOD (2004)
Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease
LS Kean et al.
BLOOD (2003)
Correction of a mouse model of sickle cell disease:: lentiviral/antisickling β-globin gene transduction of unmobilized, purified hematopoietic stem cells
DN Levasseur et al.
BLOOD (2003)
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia
R Iannone et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Effect of hydroxyurea on mortality. and morbidity in adult sickle cell anemia - Risks and benefits up to 9 years of treatment
MH Steinberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The degree of phenotypic correction of murine β-thalassemia intermedia following lentiviral-mediated transfer of a human γ-globin gene is influenced by chromosomal position effects and vector copy number
DA Persons et al.
BLOOD (2003)
Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice
S Benhamida et al.
MOLECULAR THERAPY (2003)
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
A Aiuti et al.
SCIENCE (2002)
A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation
LS Kean et al.
BLOOD (2002)
Correction of sickle cell disease in transgenic mouse models by gene therapy
R Pawliuk et al.
SCIENCE (2001)
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors
F Moreau-Gaudry et al.
BLOOD (2001)
Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia
R Iannone et al.
BLOOD (2001)
Second generation knockout sickle mice: the effect of HbF
ME Fabry et al.
BLOOD (2001)
Bone marrow transplantation without myeloablation for sickle cell disease.
L Krishnamurti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
MC Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Genetic correction of sickle cell disease: Insights using transgenic mouse models
MJ Blouin et al.
NATURE MEDICINE (2000)
Share Paper
